Financial Ratios Axcelis Technologies, Inc.
Equities
ACLS
US0545402085
Semiconductor Equipment & Testing
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.22 USD | -3.94% |
|
+0.25% | +16.03% |
| Jan. 13 | BofA Securities Adjusts Price Target on Axcelis Technologies to $100 From $90 | MT |
| Nov. 06 | Tranche Update on Axcelis Technologies, Inc.'s Equity Buyback Plan announced on March 1, 2022. | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.19 | 11.55 | 15.02 | 14.47 | 10.02 | |||||
Return on Total Capital | 7.2 | 14.09 | 20.09 | 19.93 | 13 | |||||
Return On Equity % | 11.09 | 19.33 | 30.36 | 32.15 | 21.41 | |||||
Return on Common Equity | 11.09 | 19.33 | 30.36 | 32.15 | 21.41 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 41.85 | 43.24 | 43.67 | 43.45 | 44.67 | |||||
SG&A Margin | 16.69 | 14.21 | 12.11 | 11.43 | 13.65 | |||||
EBITDA Margin % | 13.23 | 20.05 | 23.78 | 24.17 | 21.59 | |||||
EBITA Margin % | 12.23 | 19.22 | 23.08 | 23.51 | 20.71 | |||||
EBIT Margin % | 12.23 | 19.22 | 23.08 | 23.51 | 20.71 | |||||
Income From Continuing Operations Margin % | 10.53 | 14.89 | 19.9 | 21.78 | 19.75 | |||||
Net Income Margin % | 10.53 | 14.89 | 19.9 | 21.78 | 19.75 | |||||
Net Avail. For Common Margin % | 10.53 | 14.89 | 19.9 | 21.78 | 19.75 | |||||
Normalized Net Income Margin | 7.36 | 11.36 | 13.92 | 15.4 | 14.14 | |||||
Levered Free Cash Flow Margin | 6.42 | 14.65 | 12.99 | 7.27 | 9.58 | |||||
Unlevered Free Cash Flow Margin | 7.11 | 15.11 | 13.37 | 7.57 | 9.92 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.81 | 0.96 | 1.04 | 0.99 | 0.77 | |||||
Fixed Assets Turnover | 8.79 | 11.19 | 13.81 | 13.22 | 10.18 | |||||
Receivables Turnover (Average Receivables) | 5.56 | 6.93 | 6.71 | 5.83 | 4.83 | |||||
Inventory Turnover (Average Inventory) | 1.83 | 2.11 | 2.37 | 2.33 | 1.91 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.58 | 4.12 | 3.54 | 3.79 | 5.41 | |||||
Quick Ratio | 3.44 | 2.66 | 2.43 | 2.54 | 3.73 | |||||
Operating Cash Flow to Current Liabilities | 0.83 | 1 | 0.87 | 0.55 | 0.68 | |||||
Days Sales Outstanding (Average Receivables) | 65.79 | 52.7 | 54.39 | 62.59 | 75.71 | |||||
Days Outstanding Inventory (Average Inventory) | 199.89 | 172.83 | 154.04 | 156.69 | 191.28 | |||||
Average Days Payable Outstanding | 30.44 | 27.62 | 32.38 | 30.29 | 34.41 | |||||
Cash Conversion Cycle (Average Days) | 235.24 | 197.9 | 176.04 | 188.99 | 232.59 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 10.94 | 10.48 | 8.8 | 8.77 | 7.25 | |||||
Total Debt / Total Capital | 9.86 | 9.48 | 8.09 | 8.07 | 6.76 | |||||
LT Debt/Equity | 10.25 | 9.42 | 7.81 | 8.02 | 6.68 | |||||
Long-Term Debt / Total Capital | 9.24 | 8.53 | 7.18 | 7.38 | 6.23 | |||||
Total Liabilities / Total Assets | 22.9 | 28.45 | 34.17 | 32.53 | 24.91 | |||||
EBIT / Interest Expense | 11.14 | 26.33 | 38.08 | 49.71 | 38.59 | |||||
EBITDA / Interest Expense | 13.27 | 29.11 | 40.73 | 53.49 | 42.52 | |||||
(EBITDA - Capex) / Interest Expense | 11.84 | 27.31 | 38.81 | 49.63 | 40.29 | |||||
Total Debt / EBITDA | 0.76 | 0.4 | 0.26 | 0.27 | 0.32 | |||||
Net Debt / EBITDA | -2.18 | -1.69 | -1.64 | -1.5 | -2.14 | |||||
Total Debt / (EBITDA - Capex) | 0.85 | 0.43 | 0.27 | 0.29 | 0.33 | |||||
Net Debt / (EBITDA - Capex) | -2.44 | -1.81 | -1.73 | -1.62 | -2.26 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 38.37 | 39.59 | 38.88 | 22.89 | -9.97 | |||||
Gross Profit, 1 Yr. Growth % | 37.76 | 44.24 | 40.27 | 22.28 | -7.46 | |||||
EBITDA, 1 Yr. Growth % | 122.74 | 111.6 | 64.68 | 24.91 | -19.56 | |||||
EBITA, 1 Yr. Growth % | 139.79 | 119.37 | 66.79 | 25.16 | -20.69 | |||||
EBIT, 1 Yr. Growth % | 139.79 | 119.37 | 66.79 | 25.16 | -20.69 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 193.42 | 97.37 | 85.58 | 34.51 | -18.38 | |||||
Net Income, 1 Yr. Growth % | 193.42 | 97.37 | 85.58 | 34.51 | -18.38 | |||||
Normalized Net Income, 1 Yr. Growth % | 167.12 | 115.49 | 70.13 | 35.98 | -17.35 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 192 | 97.26 | 89.58 | 36.08 | -17.23 | |||||
Accounts Receivable, 1 Yr. Growth % | 3.72 | 20.2 | 62.6 | 28.39 | -6.8 | |||||
Inventory, 1 Yr. Growth % | 14.76 | 21.05 | 24.32 | 26.43 | -7.91 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.52 | 15.52 | 9.93 | 45.26 | -2.53 | |||||
Total Assets, 1 Yr. Growth % | 13.96 | 20.59 | 34.57 | 26.47 | 5.21 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.82 | 11.91 | 23.8 | 29.62 | 17.1 | |||||
Common Equity, 1 Yr. Growth % | 14.82 | 11.91 | 23.8 | 29.62 | 17.1 | |||||
Cash From Operations, 1 Yr. Growth % | -612.75 | 115.47 | 43.56 | -27.24 | -10.23 | |||||
Capital Expenditures, 1 Yr. Growth % | -37.89 | 17.27 | 22.54 | 93.35 | -41.03 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -245.78 | 218.47 | 23.17 | -31.24 | 18.68 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -290.75 | 196.68 | 22.93 | -30.47 | 18.03 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.55 | 38.98 | 39.23 | 30.64 | 5.18 | |||||
Gross Profit, 2 Yr. CAGR % | 5.14 | 40.96 | 42.24 | 30.96 | 6.38 | |||||
EBITDA, 2 Yr. CAGR % | -0.28 | 117.1 | 86.67 | 43.42 | 0.24 | |||||
EBITA, 2 Yr. CAGR % | -1.61 | 129.35 | 91.28 | 44.48 | -0.37 | |||||
EBIT, 2 Yr. CAGR % | -1.61 | 129.35 | 91.28 | 44.48 | -0.37 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 4.37 | 140.65 | 91.39 | 58 | 4.78 | |||||
Net Income, 2 Yr. CAGR % | 4.37 | 140.65 | 91.39 | 58 | 4.78 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.07 | 139.92 | 91.47 | 52.1 | 6.02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 3.99 | 140 | 93.38 | 60.62 | 6.13 | |||||
Accounts Receivable, 2 Yr. CAGR % | 5.04 | 11.65 | 39.8 | 44.48 | 9.39 | |||||
Inventory, 2 Yr. CAGR % | 11.74 | 17.86 | 22.68 | 25.37 | 7.9 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 15.53 | 9.36 | 12.69 | 26.36 | 18.98 | |||||
Total Assets, 2 Yr. CAGR % | 6.72 | 17.23 | 27.39 | 30.46 | 15.35 | |||||
Tangible Book Value, 2 Yr. CAGR % | 8.6 | 13.36 | 17.71 | 26.68 | 23.2 | |||||
Common Equity, 2 Yr. CAGR % | 8.6 | 13.36 | 17.71 | 26.68 | 23.2 | |||||
Cash From Operations, 2 Yr. CAGR % | 21.83 | 232.39 | 75.88 | 2.2 | -19.18 | |||||
Capital Expenditures, 2 Yr. CAGR % | 25.57 | -14.65 | 19.88 | 53.93 | 6.78 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -8.53 | 115.46 | 98.06 | -7.97 | -9.66 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -7.72 | 137.89 | 90.98 | -7.55 | -9.41 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.95 | 14.39 | 38.95 | 33.56 | 15.39 | |||||
Gross Profit, 3 Yr. CAGR % | 9.74 | 16.83 | 40.73 | 35.25 | 16.65 | |||||
EBITDA, 3 Yr. CAGR % | 7.85 | 28.14 | 98 | 63.28 | 18.28 | |||||
EBITA, 3 Yr. CAGR % | 6.65 | 28.53 | 106.25 | 66.06 | 18.3 | |||||
EBIT, 3 Yr. CAGR % | 6.65 | 28.53 | 106.25 | 66.06 | 18.3 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -26.71 | 29.07 | 120.69 | 70.16 | 26.77 | |||||
Net Income, 3 Yr. CAGR % | -26.71 | 29.07 | 120.69 | 70.16 | 26.77 | |||||
Normalized Net Income, 3 Yr. CAGR % | 8.44 | 30.09 | 113.95 | 70.83 | 24.12 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -27.3 | 28.73 | 121.86 | 72.01 | 28.77 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.88 | 9.87 | 26.56 | 35.89 | 24.84 | |||||
Inventory, 3 Yr. CAGR % | 10.14 | 14.76 | 19.98 | 23.92 | 13.12 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 14.94 | 15.53 | 9.55 | 22.64 | 15.89 | |||||
Total Assets, 3 Yr. CAGR % | 8.56 | 11.16 | 22.75 | 27.08 | 21.43 | |||||
Tangible Book Value, 3 Yr. CAGR % | 10.85 | 9.69 | 16.74 | 21.55 | 23.4 | |||||
Common Equity, 3 Yr. CAGR % | 10.85 | 9.69 | 16.74 | 21.55 | 23.4 | |||||
Cash From Operations, 3 Yr. CAGR % | 7.39 | 47.33 | 151.25 | 31.05 | -2.12 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.68 | 22.74 | -3.72 | 40.59 | 11.79 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 6.52 | 38.64 | 78.82 | 39.2 | 0.17 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 5.88 | 36.19 | 90.9 | 36.37 | 0.3 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.5 | 19.93 | 17.51 | 20.63 | 24.31 | |||||
Gross Profit, 5 Yr. CAGR % | 14.32 | 23.53 | 21.74 | 22.29 | 25.83 | |||||
EBITDA, 5 Yr. CAGR % | 19.65 | 47.91 | 34.32 | 34.05 | 50.8 | |||||
EBITA, 5 Yr. CAGR % | 22.86 | 49.75 | 34.73 | 34.69 | 54.17 | |||||
EBIT, 5 Yr. CAGR % | 22.86 | 49.75 | 34.73 | 34.69 | 54.17 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 27.77 | 55.07 | 7.6 | 39.94 | 63.82 | |||||
Net Income, 5 Yr. CAGR % | 27.77 | 55.07 | 7.6 | 39.94 | 63.82 | |||||
Normalized Net Income, 5 Yr. CAGR % | 29.71 | 60.5 | 36.13 | 38.48 | 61.56 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 24.4 | 51.57 | 7.52 | 40.65 | 65.19 | |||||
Accounts Receivable, 5 Yr. CAGR % | 18.7 | 15.6 | 17.66 | 22.59 | 19.39 | |||||
Inventory, 5 Yr. CAGR % | 8.04 | 11.36 | 15 | 18.89 | 14.99 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.83 | 15.52 | 14.04 | 19.75 | 13.23 | |||||
Total Assets, 5 Yr. CAGR % | 17.26 | 20.04 | 15.73 | 18.51 | 19.73 | |||||
Tangible Book Value, 5 Yr. CAGR % | 21.25 | 21.75 | 13.54 | 16.2 | 19.28 | |||||
Common Equity, 5 Yr. CAGR % | 21.25 | 21.75 | 13.54 | 16.2 | 19.28 | |||||
Cash From Operations, 5 Yr. CAGR % | 30.71 | 76.42 | 30.81 | 27.28 | 59.61 | |||||
Capital Expenditures, 5 Yr. CAGR % | 32.36 | 28.32 | 7.96 | 34.37 | 0.35 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.29 | 141.52 | 36.51 | 17.68 | 36.08 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.26 | 118.93 | 34.06 | 16.64 | 41.68 |
- Stock Market
- Equities
- ACLS Stock
- Financials Axcelis Technologies, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















